Cathie Wood's Ark Invest recap: pivots to AI drug discovery, gene editing stocks, reduces diagnostics and software exposure
Source: SeekingAlpha
2025-11-24 06:14:24 ET
More on ARK Invest
- The 3% World: The Bond Market Tells What The FED Won't Say (But Markets Don't Care)
- Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2025 Update
- ARKF: A Better-Balanced ARK ETF, But Still A Hold
- LLY joins $1T club but doesn't feature in SA's top 10 large-cap healthcare stocks
- Cathie Wood’s ARK Invest buys Nvidia shares for first time in months
Read the full article on Seeking Alpha
For further details see:
Cathie Wood's Ark Invest recap: pivots to AI drug discovery, gene editing stocks, reduces diagnostics and software exposure
ARK Genomic Revolution ETF
NASDAQ: ARKG
ARKG Trading
1.20% G/L:
$ Last:
223,320 Volume:
$36.28 Open:
